Cipla and Rocket India commit ₹300 crore to Karnataka capacity expansion
Cipla will invest ₹200 crore to expand its Bommasandra, Bengaluru facility, with production from the enlarged unit expected by December. Plant-based protein maker Rocket India has announced a ₹100 crore investment in Gokak, Karnataka.
Cipla is investing ₹200 crore to expand its Bommasandra, Bengaluru manufacturing facility, while plant-based protein maker Rocket India will invest ₹100 crore in Gokak, Karnataka. Cipla expects production from its expanded unit to begin by December.
Why this matters
The investment follows Cipla’s reported 12% India sales growth and consumer-health expansion, alongside its prioritisation of Yurpeak while delaying a semaglutide launch.
Retail-company signals are accelerating, up +163956% QoQ.